Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 2 Diabetes Mellitus

This Phase I clinical trial is a multi-center, single-arm, open-label study aimed at evaluating the safety and efficacy of RGB-5088 islet cell infusion in patients with Type 2 Diabetes Mellitus.

Participants needed: 10
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Hangzhou Reprogenix Bioscience, IncUpdated: Sep 8, 2026Locations: 1
Eligibility criteria

Age 18-65 years (inclusive), male or female. [+8]

Diagnosis of any form of diabetes other than T2DM. [+21]

Status: Recruiting

Phase I Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 1 Diabetes Mellitus

This Phase I clinical trial is a single-center, single-arm, open-label study aimed at evaluating the safety and therapeutic efficacy of RGB-5088 islet cell transplantation in patients with Type 1 Diabetes Mellitus.

Participants needed: 10
Trial details
Phase: Phase 1Age: 18-60Biological sex: AllType: InterventionalSponsor: Hangzhou Reprogenix Bioscience, IncUpdated: Sep 15, 2025Locations: 1
Eligibility criteria

Age: 18-60 years old (including 18 and 60 years old), male and female; [+3]

Type 2 diabetes patients; [+7]